ArticleInternational journal of obesity (2005)2020

The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.

Einat Gorelik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.